Sex: F
Vaccine: UNK
Symptoms: Back pain, Computerised tomogram, Erythema, Injection site induration, Injection site nodule
Clinical narrative: rash developed at injection site; rash developed at the injection site and on the back of her legs/ rash was only on left side of her body; the PREDNISONE may have caused this reaction, since she had to take it so shortly after the ZOSTAVAX vaccination; hard, warm tender knot at the injection site; hard, warm tender knot at the injection site; hard, warm tender knot at the injection site; arm was tender; back pain; measles like rash; red mark on arm with injection; This spontaneous report as received from a consumer refers to a 67 year old female patient. There were no drug reactions/ allergies. Concomitant therapies included budesonide, formoterol fumarate (SYMBICORT).  On 19-JUL-2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose and lot # unspecified) in the left arm to prevent shingles.  On 20-JUL-2014, about 24 hours after vaccination, the patient experienced hard, warm tender knot at the injection site. She stated that her arm was tender for about 2 weeks. On 28-JUL-2014, patient had to have a computed tomography (CAT) scan. On approximately 25-JUL-2014 (also reported as 3 days prior to CAT scan), she had to take prednisone. On 04-AUG-2014, the patient experienced rash developed at injection site and on the back of her legs. Rash was only on left side of her body. On an date in 2014, patient had back pain as well. The patient was concerned that prednisone could have caused this reaction, since she had to take this so shortly after zoster vaccine live (ZOSTAVAX) vaccination. No lab diagnostics were performed.   The outcome of events was unknown. The patient did not receive any treatment for the events. The patient did not seek medical attention. Product quality complaint was not involved. The reporter considered hard, warm tender knot at the injection site, arm was tender to be not related to prednisone. Causality of hard, warm tender knot at the injection site, arm was tender, rash developed at injection site and on the back of her legs with zoster vaccine live (ZOSTAVAX) was unknown.     Follow-up information was received on 20-OCT-2014 from the physician, refers to the male patient with allergy to ciprofloxacine (reported as Cipro) and contrast dye. The patient was seen by the physician on 11-AUG-2014 with healed punctate papula over left arm and left leg.  Follow-up information was received from currently the 74 years old female patient, via Pfizer, on 09-APR-2021. The patient reported that 24-FEB-2021 at 09:15, she received the first dose of coronavirus (COVID-19) vaccine (lot # EN6203) in the left arm; and on 20-MAR-2021 at 09:00, she received the second dose of that vaccine. She reported that she experienced a red mark on the arm with the first dose and measles like rash primary on arms and legs from the second injection. However, she reported that she experienced this similar reaction when she was vaccinated with zoster vaccine live (ZOSTAVAX) on 19-JUL-2014, that lasted over 44 days.  The causal assessment between the events and zoster vaccine live (ZOSTAVAX) was not provided.